Summary of all studies containing PUBCHEM ID 445580
Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
---|---|---|---|---|---|
PR001158 | ST001834 | A metabolomics comparison of plant-based meat and grass-fed meat indicates large nutritional differences despite comparable nutrition facts labels | Food item | - | Docosahexaenoic acid, 22-6, n-3 (DHA) [Data] |
PR000519 | ST000722 | Metabolomics of Diapause in Aedes albopictus | Insect | Aedes albopictus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR001415 | ST002215 | Time course GCMS based untargeted metabolomics in the presence of glucose and glycerol | Other organism | Aurantiochytrium limacinum | DHA [Data] |
PR000261 | ST000324 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 3:Ovaries) | Animal | Bos taurus | FA (22:6) (docosahexaenoic acid) [Data] |
PR000832 | ST001245 | Luteal lipids regulate progesterone production and may modulate immune cell function during the estrous cycle and pregnancy | Mammal | Bos taurus | DHA [Data] |
PR001648 | ST002556 | Blood metabolomics and impacted cellular mechanisms during transition into lactation in dairy cows that develop metritis | Mammal | Bos taurus | docosahexaenoic acid [Data] |
PR001864 | ST002994 | Integrating uterine microbiome and metabolome to advance the understanding of the uterine environment in dairy cows with metritis | Mammal | Bos taurus | docosahexaenoic acid [Data] |
PR000396 | ST000541 | Canine Diabetes - Preliminary Evaluation of Testing Methods | Animal | Canis lupus familiaris | Docosahexaenoic Acid (22:6) [Data] |
PR001013 | ST001495 | Effects of Synbiotic Administration on Fecal Microbiome and Metabolomic Profiles of Dogs receiving Antibiotics | Mammal | Canis lupus familiaris | docosahexaenoic acid [Data] |
PR001115 | ST001754 | Metabolomic Analysis of Canine Diabetes (part-II) | Mammal | Canis lupus familiaris | Docosahexaenoic Acid (22:6) [Data] |
PR000901 | ST001324 | Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress | Invertebrate | Haliotis discus hannai | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid [Data] |
PR000004 | ST000004 | Lipidomics studies on NIDDK / NIST human plasma samples | Human | Homo sapiens | DHA [Data] |
PR000008 | ST000009 | Mixed meal tolerance | Human | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000009 | ST000010 | Lung Cancer Cells 4 | Human cells | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000040 | ST000041 | High PUFA diet in humans | Human | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000041 | ST000042 | BALF Control vs ALI by RPLC-MS | Human | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000042 | ST000043 | MDA-MB-231 cells and p38 gamma knockdown | Human | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000043 | ST000044 | Pilot experiment looking for the existence of certain molecules in pancreatic cancer cells | Human | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000073 | ST000076 | A549 Cell Study | Human cells | Homo sapiens | FA(22:6)-13C0 [Data] |
PR000073 | ST000076 | A549 Cell Study | Human cells | Homo sapiens | FA(22:6)-13C1 [Data] |
PR000085 | ST000093 | Metabolomics Analysis of Frontal Fibrosing Alopecia | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000097 | ST000105 | SCOR Metabolomics | Human | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000098 | ST000106 | IWMS Study 1:Weight comparison of obese and lean patients | Human | Homo sapiens | DOCOSAHEXAENOIC ACID [Data] |
PR000102 | ST000114 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | Human cells | Homo sapiens | FA(22:6)-13C0[M-H] [Data] |
PR000102 | ST000114 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | Human cells | Homo sapiens | FA(22:6)-13C1[M-H] [Data] |
PR000102 | ST000114 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | Human cells | Homo sapiens | FA(22:6)-13C2[M-H] [Data] |
PR000102 | ST000114 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | Human cells | Homo sapiens | FA(22:6)-13C4[M-H] [Data] |
PR000121 | ST000136 | NIST lipidomics intralaboratory study | Human | Homo sapiens | FA 22:6 [Data] |
PR000127 | ST000148 | A549 13C-labeled Cell Study | Human cells | Homo sapiens | FA(22:6)-13C0 [+Na]+ [Data] |
PR000214 | ST000270 | Metabolomics in AML | Human | Homo sapiens | Docosahexaenoic Acid (22:6) [Data] |
PR000230 | ST000288 | Metabolomic profiling of AML Cell Lines | Human | Homo sapiens | Docosahexaenoic Acid (22:6) [Data] |
PR000233 | ST000292 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid [Data] |
PR000233 | ST000292 | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | Human | Homo sapiens | Docosahexaenoic Acid (22:6) [Data] |
PR000264 | ST000329 | Minimal change disease and focal segmental sclerosis in urine | Human | Homo sapiens | FA (22:6) [Data] |
PR000274 | ST000342 | Renal metabolic pathways indicating ischemic or inflammatory changes | Animal | Homo sapiens | FA (22:6) [Data] |
PR000342 | ST000444 | Preconcentration of organic solutes in urine by bubble bursting | Human | Homo sapiens | Docosahexaenoic acid [Data] |
PR000348 | ST000450 | Metabolic features of chronic fatigue syndrome | Human | Homo sapiens | Docosahexaenoic acid [Data] |
PR000357 | ST000465 | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | Human renal cancer cells | Homo sapiens | Docosahexaenoic acid [Data] |
PR000404 | ST000552 | Metabolite signatures in trauma patients with venous thromboembolism (VTE) | Human | Homo sapiens | Docosahexaenoic Acid (22:6) [Data] |
PR000451 | ST000617 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Human | Homo sapiens | Docosahexaenoic acid [Data] |
PR000488 | ST000689 | Influence of Noxa knockdown on cell metabolism | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000490 | ST000691 | Metabolomics of diabetic nephropathy | Human | Homo sapiens | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-DOCOSAHEXAENOIC ACID [Data] |
PR000492 | ST000695 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000495 | ST000698 | Metabolomics analysis of Sirt5 knockdown (KD) melanoma | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000508 | ST000711 | Microbial ecology of nontuberculous mycobacteria (NTM) in cystic fibrosis (CF) sputum | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000510 | ST000713 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000510 | ST000823 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | HUMAN | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000518 | ST000721 | Metabolomic Profiles of Recovery from Traumatic Brain Injury | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000522 | ST000725 | Metabolome, body composition, and muscle performance in children | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000523 | ST000726 | Polycystic Ovarian Syndrome(PCOS) metabolomics | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000535 | ST000741 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (fibroblast cell culture) | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000535 | ST000742 | Metabolite-phenotype link in X-linked Adrenoleukodystrophy (part II) | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000536 | ST000743 | Metabolomics of bariatric weight loss | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000537 | ST000744 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000539 | ST000748 | Placental cells (BeWo) phthalate exposure metabolomics | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000551 | ST000763 | Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000554 | ST000768 | Metabolites of human neurons and stem cells (siNeuron metabolomics) | HUMAN | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000561 | ST000775 | Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000583 | ST000818 | Integrated nutrigenomic and metabolomic analysis of Africans with variable diet | HUMAN | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000599 | ST000841 | Metabolomics of muscle in insulin sensitive and resistant obese indivduals. | HUMAN | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000599 | ST000842 | Muscle and plasma before and after exercise | HUMAN | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000611 | ST000881 | Targeted metabolomics data of leprosy patients with type 1 reaction | Human | Homo sapiens | docosahexaenoic acid [Data] |
PR000625 | ST000899 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Human serum | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000635 | ST000919 | Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics | Human | Homo sapiens | Docosahexaenoic Acid (22:6) [Data] |
PR000651 | ST000946 | Untargeted Metabolomics of T1 Participants | Human | Homo sapiens | DOCOSAHEXAENOIC ACID (M-H) [Data] |
PR000655 | ST000954 | Explore Metabolites and Pathways Associated Increased Airway Hyperresponsiveness in Asthma | Human | Homo sapiens | Docosahexaenoic Acid (22:6);Docosahexanoic Acid [Data] |
PR000657 | ST000956 | Determine metabolomics signatures important for the ability of Streptococus gallolyticus to promote colon cancer cell proliferation | Human | Homo sapiens | Docosahexaenoic Acid (22:6);Docosahexanoic Acid [Data] |
PR000658 | ST000957 | Global metabolomics of human milk fractions | Human | Homo sapiens | Docosahexaenoic Acid (22:6) [Data] |
PR000667 | ST000977 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) | Human | Homo sapiens | DHA [Data] |
PR000668 | ST000978 | Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: results from the Progredir Cohort. | Human | Homo sapiens | Doconexent, TMS derivative [Data] |
PR000756 | ST001131 | Presentation of different serum metabolites in trauma patients versus healthy volunteers. | Human | Homo sapiens | docosahexaenoic acid [Data] |
PR000758 | ST001133 | Downregulation of CENPF epigenetically remodels prostate cancer cells and alters cellular metabolism | Cultured cells | Homo sapiens | docosahexaenoic acid [Data] |
PR000814 | ST001211 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Homo sapiens | docosahexaenoic acid [Data] |
PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000960 | ST001400 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000960 | ST001516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000960 | ST001517 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000967 | ST001411 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000968 | ST001412 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001022 | ST001515 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001048 | ST001639 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001053 | ST001719 | Metabolomics Analysis of Philadelphia Cohort - Update (part-I) | Human | Homo sapiens | Docosahexaenoic Acid [Data] |
PR001053 | ST001720 | Metabolomics Analysis of ACTG Cohort -Update (part-II) | Human | Homo sapiens | Docosahexaenoic Acid [Data] |
PR001072 | ST001669 | Serum metabolome of Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Docosahexaenoic acid DHA [Data] |
PR001121 | ST001749 | REACH Metabolomics Study | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001133 | ST001780 | Comparative analysis of metabolomic profiles in cerebrospinal fluid before and after endurance exercise | Human | Homo sapiens | Docosahexaenoic acid [Data] |
PR001133 | ST001789 | Acute metabolomic changes of plasma in response to endurance exercise | Human | Homo sapiens | Docosahexaenoic acid [Data] |
PR001159 | ST001835 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001222 | ST001933 | Absolute quantification of plasma cytokines and metabolome reveals the glycylproline regulating antibody-fading in convalescent COVID-19 patients | Human | Homo sapiens | DHA [Data] |
PR001228 | ST001940 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001281 | ST002017 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001281 | ST002018 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001282 | ST002019 | TIPs Metabolomics (blood) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001287 | ST002026 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/GC) | Human | Homo sapiens | docosahexaenoic acid [Data] |
PR001432 | ST002244 | Metabolomics analysis of Friedreich's ataxia (FRDA) (part I) | Human | Homo sapiens | Docosahexaenoic acid(DHA) [Data] |
PR001500 | ST002337 | Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Docosahexaenoic acid dha [Data] |
PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001762 | ST002818 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001762 | ST002819 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001762 | ST002820 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000004 | ST000005 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Animal | Mus musculus | DHA [Data] |
PR000082 | ST000090 | Caloric Restriction vs drugs | Animal | Mus musculus | DOCOSAHEXAENOIC ACID [Data] |
PR000120 | ST000233 | Metabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice (Part II) | Animal | Mus musculus | FA(22:6) [Data] |
PR000165 | ST000693 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | Mus musculus | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000166 | ST000694 | Differences in bile acids composition between ASCL5 knockout and floxed mice. | Mouse | Mus musculus | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000211 | ST000260 | Analysis of DJ-1 Knockout Mouse Brains | Animal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000249 | ST000310 | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | Animal | Mus musculus | DHA [Data] |
PR000250 | ST000311 | TC and B6 untreated plasma in lupus-prone mice | Animal | Mus musculus | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid_1 [Data] |
PR000250 | ST000311 | TC and B6 untreated plasma in lupus-prone mice | Animal | Mus musculus | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid_2 [Data] |
PR000260 | ST000321 | Effects of LGG on current drinkers gut metabolism | Animal | Mus musculus | FA (22:6) (docosahexaenoic acid) [Data] |
PR000266 | ST000332 | Effects of Giardia intestinalis on mice GI tract | Animal | Mus musculus | FA (22:6) (docosahexaenoic acid) [Data] |
PR000271 | ST000339 | Metabolites in peritoneal macrophages and bone marrow derived macrophages | Animal | Mus musculus | FA (22:6) (docosahexaenoic acid) [Data] |
PR000281 | ST000352 | Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease | Animal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000349 | ST000451 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Animal | Mus musculus | Docosahexaenoate (Dha; 22:6N3) [Data] |
PR000349 | ST000452 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Animal | Mus musculus | Docosahexaenoate (Dha; 22:6N3) [Data] |
PR000406 | ST000554 | Metabolomics of aged iPSC | Animal | Mus musculus | Docosahexaenoic Acid (22:6) [Data] |
PR000493 | ST000696 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Mus musculus | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000499 | ST000702 | NIH 3T3 fibroblast cells with Ceftriaxone Treatment | Mouse | Mus musculus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000502 | ST000705 | Slow Aging Mice Plasma Metabolomics | Mouse | Mus musculus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000538 | ST000745 | Metabolomics of mice inoculated with human microbiota | Mouse | Mus musculus | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-DOCOSAHEXAENOIC ACID [Data] |
PR000541 | ST000751 | Mouse placentas-DEHP exposure | Mouse | Mus musculus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000580 | ST000815 | db/db WT ozone and air exposed mice | db/db mouse and WT | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000619 | ST000890 | Identification of RXR Ligands | Animals | Mus musculus | Fatty Acid C22:6 Docosahexaenoic acid [Data] |
PR000764 | ST001143 | Microbial depletion and ozone exposure - Lung tissue (part I) | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000764 | ST001144 | Microbial depletion and ozone exposure - serum (part II) | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000772 | ST001153 | Erythrocyte adenosine A2B receptor-mediated AMPK activation: Counteracting CKD by promoting oxygen delivery | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000776 | ST001157 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000776 | ST001158 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR000867 | ST001282 | Role of Hi1a in mitochondrial metabolic rewiring in M1 Macrophages | Cultured cells | Mus musculus | docosahexaenoic acid [Data] |
PR000989 | ST001439 | Metabolites in contents of small intestine in wild type and DAOG181R/G181R mice | Bacteria | Mus musculus | cis-4,7,10,13,16,19-Docosahexaenoic acid [Data] |
PR001031 | ST001606 | Aromatic amino acid metabolism by the anaerobic gut bacterium Clostridium sporogenes | Mammal | Mus musculus | docosahexaenoic acid [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | cis-4,7,10,13,16,19-Docosahexaenoic acid [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | FA 22:6; (docosahexaenoic acid) [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | cis-4,7,10,13,16,19-Docosahexaenoic acid [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | FA 22:6; (docosahexaenoic acid) [Data] |
PR001051 | ST001643 | Deletion of the diabetes candidate gene Slc16a13 in mice | Mammal | Mus musculus | docosahexaenoic acid [Data] |
PR001129 | ST001775 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001139 | ST001795 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mammal | Mus musculus | FA (14:1) tetradecenoic acid [Data] |
PR001162 | ST001840 | Metabolomics of lung microdissections reveals region- and sex-specific metabolic effects of acute naphthalene exposure in mice (part I) | Mammal | Mus musculus | FA 22:6 [Data] |
PR001170 | ST001855 | The metabolomic resetting effect of FG4592 in AKI to CKD transition (Part 1) | Mammal | Mus musculus | Docosahexaenoic acid [Data] |
PR001170 | ST001856 | The metabolomic resetting effect of FG4592 in AKI to CKD transition (Part 2) | Mammal | Mus musculus | Docosahexaenoic acid [Data] |
PR001178 | ST001865 | Systemic metabolite changes due to Hypoxia | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001178 | ST001866 | Systemic metabolite changes due to PHD inhibition | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001238 | ST001951 | Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. | Mammal | Mus musculus | DHA [Data] |
PR001366 | ST002153 | Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 | Mammal | Mus musculus | cis-4,7,10,13,16,19-Docosahexaenoic acid-2 [Data] |
PR001373 | ST002160 | Global metabolomics analysis of neutrophils isolated from tumor | Mammal | Mus musculus | Docosahexaenoic Acid [Data] |
PR001416 | ST002216 | Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received metronidazole using high-resolution, high-performance LC-MS/MS analysis. | Mammal | Mus musculus | Docosahexaenoic Acid [Data] |
PR001416 | ST002217 | Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received 1% choline supplementation or control diet using high-resolution, high-performance LC-MS/MS analysis. | Mammal | Mus musculus | Docosahexaenoic acid [Data] |
PR001419 | ST002228 | Estrogen receptor a deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 2) | Mammal | Mus musculus | Docosahexaenoic acid [Data] |
PR001468 | ST002465 | Map of microbially induced metabolic changes across diverse body sites in mice - Mouse Data | Mammal | Mus musculus | Docosahexaenoic acid [Data] |
PR001524 | ST002371 | High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages | Cultured cells | Mus musculus | docosahexaenoate(DHA) [Data] |
PR001583 | ST002455 | Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation | Mammal | Mus musculus | DHA [Data] |
PR001585 | ST002457 | Mouse kidney metabolomics (Whole kidney) | Mammal | Mus musculus | Docosahexaenoic Acid [Data] |
PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001748 | ST002817 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Mammal | Mus musculus | FA 22:6 (docosahexaenoic acid) [Data] |
PR001776 | ST002836 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001776 | ST002837 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001945 | ST003131 | Untargeted Metabolomics on mouse caecal contents | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001945 | ST003132 | Untargeted Metabolomics on Mouse colonic mucosa | Mammal | Mus musculus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001290 | ST002043 | Maternal Hypoxemia and Oxidative Stress | Mammal | Ovis aries | docosahexaenoic acid [Data] |
PR000665 | ST000972 | High Resolution GC-MS Metabolomics of Non-Human Primate Serum | Other | Papio hamadryas | Docosahexaenoic acid [Data] |
PR000016 | ST000017 | Rat HCR/LCR Stamina Study | Animal | Rattus norvegicus | DOCOSAHEXAENOIC ACID [Data] |
PR000204 | ST000252 | Impact of recurrent hypoglycemia on brain metabolite profile | Animal | Rattus norvegicus | Docosahexaenoic Acid (22:6) [Data] |
PR000275 | ST000343 | Modification of metabolites by gut microbiota in response to diet | Animal | Rattus norvegicus | FA (22:6) [M-H]- (docosahexaenoic acid) [Data] |
PR000375 | ST000555 | Cocaine administration and withdrawal (part II) | Long Evans Rat | Rattus norvegicus | Docosahexaenoic Acid (22:6) [Data] |
PR000437 | ST000600 | NEFA Profile Response to Triphenyl Phosphate Exposure | Animal | Rattus norvegicus | C20:4n3 [Data] |
PR000540 | ST000749 | Rat amniotic fluid metabolomics | Rat | Rattus norvegicus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000540 | ST000750 | Rat amniotic fluid metabolomics (part II) | Rat | Rattus norvegicus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000545 | ST000756 | Metabolomics of cilia and modulation of renal microcirculation | Rat | Rattus norvegicus | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR000548 | ST000759 | Age and exercise effect on metabolomics in rats | Rat | Rattus norvegicus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000627 | ST000903 | Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament | Animal | Rattus norvegicus | Docosahexaenoic acid [Data] |
PR001027 | ST001526 | Mitochondrial health is enhanced in rats with higher vs. lower intrinsic exercise capacity and extended lifespan | Mammal | Rattus norvegicus | docosahexaenoic acid [Data] |
PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | docosahexaenoate (DHA; 22:6n3) [Data] |
PR001285 | ST002023 | A targeted metabolomics study for assessing rodent thyroid toxicity | Mammal | Rattus norvegicus | Fatty Acids__DHA [Data] |
PR001320 | ST002080 | Effects of Ferroptosis on the Metabolome in Cardiac Cells: The Role of Glutaminolysis | Cultured cells | Rattus norvegicus | Doconexent [Data] |
PR001511 | ST002354 | Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. | Mammal | Rattus norvegicus | Docosahexaenoic acid [Data] |
PR001719 | ST002758 | Metabolic responses of normal rat kidneys to a high salt intake (Plasma) | Mammal | Rattus norvegicus | Docosahexaenoic acid [Data] |
PR000235 | ST000294 | Mechanisms of Metabolic Cycles in Diapausing Flesh Fly by Metabolomics Approach | Insect | Sarcophaga crassipalpis | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid [Data] |
PR001468 | ST002289 | Map of microbially induced metabolic changes across diverse body sites in mice - Bacterial culture data | Bacteria | Several mouse commensals | Docosahexaenoic acid [Data] |
PR000697 | ST001041 | Development of a weaned pig model of enterotoxigenic E.coli-induced environmental enteropathy | Mammal | Sus scrofa | docosahexaenoic acid [Data] |
PR000521 | ST000724 | Red squirrels age related changes | Animal | Tamiasciurus hudsonicus | DOCOSAHEXAENOIC ACID (M-H)- [Data] |
PR000414 | ST000692 | Metabolites produced by strains associated with inflammation | Bacteria | Treponema pectinovorum | DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)- [Data] |
PR001635 | ST002539 | Microbial metabolomic responses to changes in temperature and salinity along the western Antarctic Peninsula. | Water sample | Docosahexaenoic acid [Data] |